MENU

Aligning In-House and Commercial Analytical Testing Workflows for Cannabis Producers and Processors

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Chief Science Officer, Ionization Labs
    Biography

      Shawn obtained Bachelor of Science (B.Sc.) degrees in Chemistry, and Biochemistry/Molecular Biology from the University of Minnesota Duluth. He earned a Master of Science (M.Sc.) in Analytical Chemistry from the University of Minnesota studying supercritical fluid separation theory, and adult education. Shawn Joined Waters Corporation in 2015 as a product development and applications chemist in the SFx separations product development and marketing group. Considered a subject matter expert in applications and systems utilizing carbon dioxide (CO2) as a solvent, Shawn consulted with internal and external stakeholders on systems research and design, product development, and applications utilizing CO2-based technology. In 2019 Shawn joined Deutsche Process as Chief Scientific Officer and was involved with new product research and development and scientific evaluation of new and existing technology for implementation in emerging markets. In 2020 Shawn joined Ionization Labs, a Green Ocean Sciences Company, as Chief Scientific Officer. Ionization Labs is a life sciences solutions and software provider. Shawn blends his background in analytical and industrial systems development, natural products application research, and new product research, development, and marketing to deliver robust, innovative, and intuitive application and software solutions in support of new and emerging markets. He collaborates with the business and software development teams to support and manage new product research, development, and marketing of Ionization Lab's flagship cannabis potency testing solution, Cann-ID, as well as supports the science team in Ionization Lab's commercial ISO 17025:2017 accredited cannabinoid testing laboratory.


    Abstract

    Accurate and reliable analytical cannabinoid potency data is essential to operating a compliant, consistent, and profitable cannabis company. Third-party testing labs service this industry need by offering testing as a service to cannabis companies. Since testing labs have a vested interest in the sustained success of their clients, successful lab-client relationships are usually more akin to a partnership than a simple service provider. Testing labs understand that supporting their clients throughout the cannabis product development lifecycle is mutually beneficial and endears their clients to their suite of professional laboratory services. However, third-party analytical potency testing at the levels required to sustain good manufacturing practices and to ensure the quality, consistency, and efficiency of manufacturing processes is extremely expensive. Additionally, the informational lag from the sampling-to-result turnaround time creates opportunity for costly process inefficiencies to linger resulting in lost profit margins on manufactured products or increased time-to-market. Supplementing confirmatory third-party potency testing with in-house potency testing significantly decreases the cost and lag time associated with obtaining the analytical information required to operate a successful cannabis business. This talk will focus on the testing needs of cannabis operations requiring high testing volumes such as processors and other vertically integrated businesses and multi-state operators. It will outline how in-house and commercial testing workflows can be aligned through the standardization of analytical hardware, cloud-based software, and sample preparation, analysis, and quantitation methods. A new collaborative testing model is described for democratizing cannabis potency testing, while expanding the professional laboratory services offered by commercial cannabis testing laboratories.

    Learning Objectives:

    1. Attendees will recognize the benefits of both commercial and in-house testing programs and will be able to identify when to use each.

    2. Attendees will have the tools to assess costs associated with several different testing programs available to cannabis businesses.

    3. Attendees will realize how commercial laboratories can utilize software to collaborate with in-house testing operations more effectively and create new laboratory service models for their clients.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    APR 19, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 19, 2021 8:00 AM PDT
    Date: Apri 19, 2021 Time: 8:00am PDT, 5:00pm CEST Since the inception of modern biological research, BioSafety has evolved into a critical consideration in Good Laboratory Practices (GLP). Wi...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources
    Attendees
    • See more